Up to January 23, 2026, the calculation of basic net income per ordinary share for the three and six months ended June 30, 2026 excluded 978,750 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the Underwriters. On January 23, 2026, the Underwriters’ over-allotment option was exercised in full simultaneously with the closing of the Initial Public Offering, and the 978,750 Class B ordinary shares were no longer subject to forfeiture.

CONDENSED STATEMENT OF CASH FLOWS	6 Months Ended
CONDENSED STATEMENT OF CASH FLOWS	Jun. 30, 2026 USD ($)
Cash Flows from Operating Activities:
Net income	$ 2,887,889
Adjustment to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(3,749,962)
Changes in operating assets and liabilities:
Prepaid insurance	(101,523)
Accounts payable	22,554
Accrued expenses	40,782
Due to related party	10,000
Net cash used in operating activities	(890,260)
Cash Flows from Investing Activities:
Cash deposited into Trust Account	(300,150,000)
Net cash used in investing activities	(300,150,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting fees and reimbursement paid	294,907,388
Proceeds from sale of Private Placement Warrants	7,300,000
Payment of offering costs	(99,481)
Proceeds from promissory note - related party	50,000
Payment of promissory note - related party	(250,000)
Net cash provided by financing activities	301,907,907
Net Change in Cash	867,647
Cash - Beginning of period	23,583
Cash - End of period	891,230
Supplemental disclosure of non-cash investing and financing activities:
Deferred underwriting fee payable	$ 12,789,000

CONDENSED BALANCE SHEETS - USD ($)

Jun. 30, 2026

Dec. 31, 2025

Current assets:

Cash

$ 891,230

$ 23,583

Prepaid insurance

101,523

Total current assets

992,753

23,583

Marketable securities held in Trust Account

303,899,962

Deferred offering costs

261,481

TOTAL ASSETS

304,892,715

285,064

Current liabilities:

Accounts payable

33,800

11,246

Accrued expenses

53,907

13,125

Accrued offering costs

2,724

113,775

Due to related party

$ 10,000

Other Liability, Current, Related Party [Extensible Enumeration]

Related Party [Member]

Promissory note - related party

$ 200,000

Notes Payable, Current, Related Party [Extensible Enumeration]

Related party

Total current liabilities

$ 100,431

$ 338,146

Deferred underwriting fee payable

12,789,000

Total Liabilities

12,889,431

338,146

Commitments and Contingencies (Note 7)

Shareholders' Deficit:

Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding as of June 30, 2026 and December 31, 2025

Additional paid-in capital

24,250

Accumulated deficit

(11,897,428)

(78,082)

Total Shareholders' Deficit

(11,896,678)

(53,082)

TOTAL LIABILITIES, REDEEMABLE CLASS A ORDINARY SHARES AND SHAREHOLDERS' DEFICIT

304,892,715

285,064

Common Class A subject to possible redemption

Current liabilities:

Class A ordinary shares subject to possible redemption, 30,015,000 and 0 shares at redemption value of $10.12 and $0.00 per share as of June 30, 2026 and December 31, 2025, respectively

303,899,962

Class B ordinary shares

Shareholders' Deficit:

Ordinary shares

^[1]

$ 750

[1]

At December 31, 2025, included up to 978,750 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (Note 6). On January 23, 2026, the Underwriters’ over-allotment option was exercised in full simultaneously with the closing of the Initial Public Offering, and the 978,750 Class B ordinary shares were no longer subject to forfeiture.